Stigma and Psychological profilE in REctal-anal caNcer pAtients
Conditions: Rectal Cancer; Anal Cancer Interventions: Other: Psychological tests administration Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Patient Reported Outcomes (PROs) in Anal Cancer Patient Treated by Intensity Modulated Radiotherapy (IMRT).
Conditions: Anal Cancer Patients Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers
Conditions: Cervical Cancer; Anal Cancer; Head and Neck Cancers; Other Solid Tumors Interventions: Drug: CRTE7A2-01 TCR-T cell therapy Sponsors: Corregene Biotechnology Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Open Pilot Trial of a Mind-Body Sexual Well-Being Intervention for Female GI Cancer Survivors
Conditions: Colorectal Cancer; Anal Cancer; Sexual Dysfunction Interventions: Behavioral: Mind-Body Group Intervention Sponsors: Massachusetts General Hospital; Harvard Medical School (HMS and HSDM) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity ™ HPV Assay on Anal Specimens
Conditions: Anal Intraepithelial Neoplasia 2; Anal Intraepithelial Neoplasia 1; Anal Cancer; High-Risk Cancer Sponsors: European Institute of Oncology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Conditions: Gastrointestinal Cancer; Colon Cancer; Rectal Cancer; Anal Cancer; Esophageal Cancer; Stomach Cancer; Appendix Cancer; Pancreas Cancer; Liver Cancer; Neuroendocrine Tumors Interventions: Other: EQUITY GI Sponsors: Case Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas
Conditions: Squamous Cell Carcinoma of the Head and Neck; Squamous Cell Carcinoma of the Anus Interventions: Other: Multiparameter analysis of each sample Sponsors: National Cancer Institute, Naples Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2024 Category: Research Source Type: clinical trials
Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA
Conditions: Anal Cancer Interventions: Drug: induction chemotherapy (mDCF); Drug: Concomitant chemotherapy (Capecitabin + Mitomycin-C); Radiation: radiotherapy Sponsors: Federation Francophone de Cancerologie Digestive; Fondation ARCAD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
Prospective Randomized Phase III Study Evaluating Induction Chemotherapy (Modified DCF) Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced Anal Squamous Cell Carcinoma (T3-4 or N1a, b or c)
Conditions: Anal Cancer Interventions: Drug: induction chemotherapy (mDCF); Drug: Concomitant chemotherapy (Capecitabin + Mitomycin-C); Radiation: radiotherapy Sponsors: Federation Francophone de Cancerologie Digestive; Fondation ARCAD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 17, 2024 Category: Research Source Type: clinical trials
MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach
Condition: Anal Squamous Cell Carcinoma Interventions: Radiation: Radiotherapy - Low risk group; Radiation: Radiotherapy - Standard risk group; Radiation: Radiotherapy - Intermediate risk group; Radiation: Radiotherapy - High risk group Sponsor: University Health Network, Toronto Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2023 Category: Research Source Type: clinical trials
